Link: University of Iowa

Archive for the ‘Samuel Trammell’ Category

Samuel Trammell receives special Graduate Deans’ Distinguished Dissertation Award

Thursday, July 13th, 2017

Dr. Samuel Trammell, a 2016 Genetics PhD with Dr. Charles Brenner, is the recipient of a Graduate Deans’ Distinguished Dissertation Award for his dissertation entitled “Novel NAD+ Metabolomics Technologies and Their Applications to Nicotinamide Riboside Interventions.” The Graduate Deans’ Distinguished Dissertation Award is made only occasionally and recognizes exceptionally meritorious scholarship. Dr. Trammell will be recognized at the 20th Annual James F. Jakobsen Memorial Research Conference on Saturday, March 24, 2018, at the Iowa Memorial Union. Dr. Trammell is currently a postdoctoral fellow at the University of Copenhagen with Dr. Matthew Gillium working on lipid metabolism in diabetes.

 

Brenner lab treats type 2 diabetic neuropathy with nicotinamide riboside

Tuesday, May 31st, 2016

In the new study, published May 27 in the journal Scientific Reports, Dr. Charles Brenner, together with Randy Kardon, MD, PhD, and Mark Yorek, PhD, who are jointly affiliated with University of Iowa Health Care and the Iowa City VA Health System, and Samuel Trammell (2016 PhD, Brenner laboratory), tested the effects of NR supplementation on mouse models of prediabetes and type 2 diabetes. Read more about their study here: http://www.eurekalert.org/pub_releases/2016-05/uoih-vnr052616.php

Samuel Trammell successfully defends PhD thesis

Tuesday, February 23rd, 2016

Oonthonpan and TrammellSamuel Trammell, a genetics PhD Student mentored by Dr. Charles Brenner, successfully defended his thesis on February 22, 2016, entitled “Novel NAD+ metabolomic technologies and their applications to nicotinamide riboside interventions.” Sam has accepted a position as a postdoctoral fellow at the University of Copenhagen with Dr. Matthew Gillium working on lipid metabolism in diabetes.

Congratulations, Dr. Trammell!

Samuel Trammell’s poster is runner up at CVC Symposium

Thursday, October 31st, 2013

Samuel Trammell, of the Brenner laboratory, received runner up in the Student/Postdoc category for his poster “NAD+ Metabolomics and Its Application to Nicotinamide Riboside Therapies in Rodents” at the Cardiovascular Research Center (CVC) Symposium: Academic Research at a Crossroads this month. There were 110 posters presented at the symposium. Congratulations, Sam!